Event: Novel Anti-Seizure Compound ANAVEX 2-73 a Sigma-1 Receptor Agonist in Multiple Seizure Models Date/Time: Monday, December 7, 2015 8:00 a.m. – 2:00 p.m. Location: Pennsylvania Convention Center, Hall A, 200 Level, Philadelphia, PA
Event: Alzheimer’s case study (Anavex pipeline) by Christopher U. Missling, PhD, President and Chief Executive Officer Date/Time: Tuesday, December 8, 2015 Location: U.S. Capitol Visitor Center, Washington, D.C.
Event: Corporate Overview by Christopher U. Missling, PhD, President and Chief Executive Officer Date/Time: Wednesday, December 9, 2015 9:10 a.m. ET Location: Mandarin Oriental, 36th Floor, 80 Columbus Circle Drive, New York, NY